Skip to main content
Equibles

Larson Financial Group LLC

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 1731061 ST LOUIS, MO
Back to TNXP Full portfolio

Position in TNXP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$124,091
+$110,491 QoQ
Shares Held
9,725
Ownership
0.057%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#54
of 103 holders
Holding Since
Dec 2020
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in TNXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Larson Financial Group LLC holds $5,718,078 across 194 Biotechnology names. TNXP ranks #13 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,302 $646,742
2 INCY
Incyte Corp
 4,050 $459,108
3 TGTX
Tg Therapeutics, Inc.
 7,292 $400,622
4 REGN
Regeneron Pharmaceuticals, Inc.
 627 $390,959
5 EXEL
Exelixis, Inc.
 4,507 $245,225
6 IONS
Ionis Pharmaceuticals Inc
 3,000 $237,870
7 ALNY
Alnylam Pharmaceuticals, Inc.
 613 $184,531
8 JAZZ
Jazz Pharmaceuticals plc
 709 $170,847

All Filings in TNXP

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $124,091 9,725
2020-12-31 $13,600 20,000